Pharma Ag Novartis - Net Worth and Insider Trading
Pharma Ag Novartis Net Worth
The estimated net worth of Pharma Ag Novartis is at least $0 dollars as of 2024-11-05. Pharma Ag Novartis is the 10% Owner of Regeneron Pharmaceuticals Inc and owns about 0 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $0. Details can be seen in Pharma Ag Novartis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pharma Ag Novartis has not made any transactions after 2005-11-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Pharma Ag Novartis
Pharma Ag Novartis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pharma Ag Novartis owns 5 companies in total, including Cellular Biomedicine Group Inc (CBMG) , Poseida Therapeutics Inc (PSTX) , and Alnylam Pharmaceuticals Inc (ALNY) among others .
Click here to see the complete history of Pharma Ag Novartis’s form 4 insider trades.
Insider Ownership Summary of Pharma Ag Novartis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CBMG | Cellular Biomedicine Group Inc | 2020-08-11 | 10 percent owner |
| PSTX | Poseida Therapeutics Inc | 2020-07-09 | 10 percent owner |
| ALNY | Alnylam Pharmaceuticals Inc | 2012-09-20 | 10 percent owner |
 | | 2005-11-08 | 10 percent owner |
| | 2022-06-15 | 10 percent owner |
Pharma Ag Novartis Latest Holdings Summary
Pharma Ag Novartis currently owns a total of 1 stock. Pharma Ag Novartis owns 0 shares of Regeneron Pharmaceuticals Inc (REGN) as of November 8, 2005, with a value of $0.
Latest Holdings of Pharma Ag Novartis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2005-11-08 | 0 | 829.43 | 0 |
Holding Weightings of Pharma Ag Novartis
Pharma Ag Novartis Form 4 Trading Tracker
According to the SEC Form 4 filings, Pharma Ag Novartis has made a total of 0 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 7,527,050 shares on November 8, 2005, which brought Pharma Ag Novartis around $83 Million.
Insider Trading History of Pharma Ag Novartis
- 1
Pharma Ag Novartis Trading Performance
Pharma Ag Novartis Ownership Network
Ownership Network List of Pharma Ag Novartis
Ownership Network Relation of Pharma Ag Novartis
Pharma Ag Novartis Owned Company Details
What does Cellular Biomedicine Group Inc do?
Who are the key executives at Cellular Biomedicine Group Inc?
Pharma Ag Novartis is the 10 percent owner of Cellular Biomedicine Group Inc. Other key executives at Cellular Biomedicine Group Inc include 10 percent owner Ag Novartis , 10 percent owner Maplebrook Ltd , and 10 percent owner Sailing Capital Overseas Investments Fund, LP .
Cellular Biomedicine Group Inc (CBMG) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cellular Biomedicine Group Inc (CBMG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cellular Biomedicine Group Inc (CBMG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cellular Biomedicine Group Inc (CBMG)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cellular Biomedicine Group Inc Insider Transactions
Pharma Ag Novartis Mailing Address
Above is the net worth, insider trading, and ownership report for Pharma Ag Novartis. You might contact Pharma Ag Novartis via mailing address: Lichtstrasse 35, Ch-4002, Basel V8.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
